Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypersensitivity Reactions: Cytolytic Reactions

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Drug toxicity: Idiosyncratic Reactions

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Medical conditions of children and young people with Down syndrome.

Journal of intellectual disability research : JIDR·2021

Same author

Atrioventricular canal defect and genetic syndromes: The unifying role of sonic hedgehog.

Clinical genetics·2018

Same author

Psychological factors associated with NAFLD/NASH: a systematic review.

European review for medical and pharmacological sciences·2017

Same author

Functional recovery after experimental spinal cord compression and whole body vibration therapy requires a balanced revascularization of the injured site.

Restorative neurology and neuroscience·2014

Same author

Nitrogen removal performance of intermittently aerated membrane bioreactor treating black water.

Environmental technology·2014

Same author

Syndromic non-compaction of the left ventricle: associated chromosomal anomalies.

Clinical genetics·2012

Search research articles

Related Experiment Video

Updated: Jun 17, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Nevirapine hypersensitivity.

M Popovic¹, J M Shenton, J Chen

¹Department of Pharmaceutical Sciences, University of Toronto, Toronto, Canada.

Handbook of Experimental Pharmacology

|December 19, 2009

Summary

This summary is machine-generated.

Nevirapine treatment for HIV-1 can cause severe skin and liver toxicity. A rat model reveals the rash is immune-mediated, linked to a nevirapine metabolite, not the parent drug.

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Related Experiment Videos

Last Updated: Jun 17, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Reverse Genetics to Engineer Positive-Sense RNA Virus Variants

Published on: June 9, 2022

Area of Science:

Immunology
Pharmacology
Toxicology

Background:

Nevirapine, used for HIV-1 treatment, is linked to significant skin and liver toxicities, ranging from mild to life-threatening.
Understanding the mechanisms of these idiosyncratic drug reactions is crucial for patient safety.

Purpose of the Study:

To investigate the immune-mediated mechanisms underlying nevirapine-induced skin rash using a newly developed rat model.
To identify whether the parent drug or its metabolites are responsible for initiating the immune response.

Main Methods:

Utilized a rat model that mimics human nevirapine-induced skin rash.
Investigated the role of T-cell subsets (CD4+ and CD8+) by assessing protection after partial depletion.
Compared immune responses to the parent drug versus its 12-hydroxy metabolite in vivo and ex vivo.

Main Results:

The nevirapine-induced skin rash in rats is immune-mediated and partially prevented by CD4+ T-cell depletion.
The rash is primarily associated with the 12-hydroxy metabolite of nevirapine, not the parent drug.
Ex vivo T-cell cytokine responses do not accurately reflect in vivo immune activation by the drug or its metabolite.

Conclusions:

The rat model is a valuable tool for studying nevirapine-induced skin rash mechanisms.
Immune responses are triggered by a nevirapine metabolite, highlighting the complexity of idiosyncratic drug reactions.
In vitro T-cell assays may not reliably predict in vivo drug-induced immune responses.